NCT02507609View on ClinicalTrials.gov

Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

September 8, 2015

Primary Completion Date

April 26, 2018

Study Completion Date

April 26, 2018

Conditions
Hip Fractures
Interventions
OTHER

Moderate neuromuscular blockade

TOF count is maintained to 1 to 2 by intermittent intravenous injection of rocuronium bromide 5 mg during operation

OTHER

Deep neuromuscular blockade

PTC is maintained to 1 to 2 degree by continuous infusion of rocuronium bromide intravenous route

Trial Locations (1)

143-729

Konkuk University Medical Center, Seoul

All Listed Sponsors
lead

Konkuk University Medical Center

OTHER

NCT02507609 - Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium | Biotech Hunter | Biotech Hunter